NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) ...
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
A multi-omics atlas reveals how centenarians maintain potent cytotoxic NK and T cell circuits, offering clues to designing therapies that counteract immune decline with age. Study: A comprehensive ...
Chronic diabetic ulcers represent one of the most challenging complications in modern healthcare, affecting over 131 million people worldwide and generating approximately $755 billion in annual ...
In addition to strengthening the muscles, lungs, and heart, regular physical exercise also strengthens the immune system. This finding comes from a study of older adults with a history of endurance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results